These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8884351)

  • 21. Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours.
    Hall RE; Clements JA; Birrell SN; Tilley WD
    Br J Cancer; 1998 Aug; 78(3):360-5. PubMed ID: 9703283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progesterone-binding cyst protein (PBCP = GCDFP-24) and steroid hormone receptors as markers of differentiation in breast cancer. Inverse relation of distribution in normal and malignant tissue of the same breast.
    Søreide JA; Lea OA; Kvinnsland S
    Anticancer Res; 1991; 11(3):1323-6. PubMed ID: 1888167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric metastasis of mammary signet ring cell carcinoma--a differential diagnosis with primary gastric signet ring cell carcinoma.
    Yim H; Jin YM; Shim C; Park HB
    J Korean Med Sci; 1997 Jun; 12(3):256-61. PubMed ID: 9250925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
    Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
    Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
    Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of neuroendocrine carcinoma of the breast.
    Sapino A; Papotti M; Righi L; Cassoni P; Chiusa L; Bussolati G
    Ann Oncol; 2001; 12 Suppl 2():S115-7. PubMed ID: 11762336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
    Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ
    Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical correlates of morphologic differentiation in human breast cancer.
    Silva JS; Cox CE; Wells SA; Paull D; Dilley WG; McCarty KS; Fetter BF; Glaubitz LC; McCarty KS
    Surgery; 1982 Sep; 92(3):443-9. PubMed ID: 7202259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the primary site of metastatic adenocarcinoma in serous effusions. Value of an immunocytochemical panel added to the clinical arsenal.
    Longatto Filho A; Alves VA; Kanamura CT; Nonogaki S; Bortolan J; Lombardo V; Bisi H
    Acta Cytol; 2002; 46(4):651-8. PubMed ID: 12146025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer.
    Huo L; Zhang J; Gilcrease MZ; Gong Y; Wu Y; Zhang H; Resetkova E; Hunt KK; Deavers MT
    Histopathology; 2013 Jan; 62(2):267-74. PubMed ID: 22963676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15,000.
    Le Doussal V; Zangerle PF; Collette J; Spyratos F; Hacene K; Briere M; Franchimont P; Gest J
    Eur J Cancer Clin Oncol; 1985 Jun; 21(6):715-25. PubMed ID: 3894034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunohistochemical comparison between GCDFP-15 and estrogen and progesterone receptors in the diagnosis of metastatic carcinoma of the breast].
    Villarroel Salinas J; Ortiz Hidalgo C; Soria Céspedes D
    Gac Med Mex; 2012; 148(3):213-7. PubMed ID: 22820353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serous cystadenocarcinoma of the ovary with simultaneous breast metastases. Description of a case].
    Manini C; Pietribiasi F; Sapino A; Donadio S
    Pathologica; 1998 Apr; 90(2):152-5. PubMed ID: 9619059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site.
    Brown RW; Campagna LB; Dunn JK; Cagle PT
    Am J Clin Pathol; 1997 Jan; 107(1):12-9. PubMed ID: 8980361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of cytokeratin 7 and 20 in ovarian metastatic carcinomas].
    Dai L; Song Q; Li L; Zhong D; Hui Y
    Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):114-7. PubMed ID: 11866966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful.
    Barnetson RJ; Burnett RA; Downie I; Harper CM; Roberts F
    Am J Clin Pathol; 2006 Jan; 125(1):67-76. PubMed ID: 16482993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens.
    Fiel MI; Cernaianu G; Burstein DE; Batheja N
    Acta Cytol; 1996; 40(4):637-41. PubMed ID: 8693878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
    Berezowski K; Stastny JF; Kornstein MJ
    Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin.
    Wendroth SM; Mentrikoski MJ; Wick MR
    Ann Diagn Pathol; 2015 Feb; 19(1):6-9. PubMed ID: 25544392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas.
    Staebler A; Sherman ME; Zaino RJ; Ronnett BM
    Am J Surg Pathol; 2002 Aug; 26(8):998-1006. PubMed ID: 12170086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.